Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Problem Behavior

• Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
• HNC: Human Neural Circuits Electrophysiology During Cognition
• Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).
• Ketamine and Stress in OCD
• MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva
• A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
• Pramipexole for Anhedonic Depression
• Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities
• Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations
• Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam
• Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability
• Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study
• Adjunctive Celecoxib in Childhood-onset OCD Study
• Prospecta in the Treatment of Cognitive, Behavioural and Psychiatric Disorders in Patients With Vascular Dementia.
• Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
• FAAH Availability in Psychiatric Disorders: A PET Study
• Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults
• Clinical Utility of Pharmacogenomics of Psychotropic Medications
• Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
• Prazosin for Agitation in Alzheimer's Disease
• Substance Misuse To Psychiatric Disorders for Cannabis
• Stimulant Effects on Disruptive Behavior
• Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
• ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
• The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia
• Cannabinoids for Behavioral Problems in Children With ASD
• Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
• Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
• Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
• Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI
• A Study of Combination Therapy in Children With ADHD
• A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
• Sequenced Therapies for Comorbid and Primary Insomnias
• Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
• Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
• Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
• Effect of the Electronic Cigarette on Withdrawal Symptoms
• Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
• Delta-THC in Behavioral Disturbances in Dementia
• Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
• Influence of Oxytocin on the Startle Reflex and on Its Modulation
• A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
• Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems
• A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
• Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
• A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
• A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
• A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
• A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
• A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
• A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
• Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
• Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
• Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
• Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)